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The immune response of mice infected with Trypanosoma

cruzi

(the

causative agent of Chagas' disease) has been extensively studied, and it has
been demonstrated t h a t changes in environmental t e m p e r a t u r e can
influence the resistance of infected mice to the parasite.

In particular,

several investigators have demonstrated an increased resistance to T. cruzi
infection when infected mice are maintained at 36°C.

This increased

resistance is reflected in decreased parasitemias and increased longevity.
In addition, this enhanced resistance h a s been shown to be

an

immunological phenomenon. CD4+ T cells play a very important role in
i m m u n e responses to parasitic infections through the secretion of
cytokines.

To explore a possible role for CD4+ T cells in this enhanced

resistance to parasitic infection, anti-CD4 monoclonal antibody was used to
deplete CD4+ T cells prior to infection. Parasitemia and mortality of mice
were monitored under different environmental conditions. The results of
this experiment indicate t h a t 1) CD4+ T cells do play a role in this
temperature related resistance to the parasite; 2) CD4+ T cells were
particularly necessary early in infection for mice maintained at higher
temperature to establish a protective resistance to T. cruzi\ 3) enhanced
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resistance to T. cruzi at elevated temperature also involves CD4+ T cell
independent pathways; 4) Elevated temperature may have an enhancing
effect upon the activity of CD4+ T cells.
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INTRODUCTION
The role of CD4+ T cells in parasitic infection
After a host is infected by a parasite, a variety of different immune
responses can be invoked. Certain subsets of T lymphocytes that can secrete
distinct patterns of cytokines play a major role in the regulation of these
responses.
The CD4+ T cell is one of the major subsets of mature T cells. These
cells bear a specific surface marker, the CD4 molecule,

which is a

glycoprotein of approximately 55 kilodalton (ED) (Kuby, 1992). CD4+ T cells
are also called T helper cells, these cells play a key role in the regulation of
the immune response by secreting different cytokines.
The CD4+ T cells can be further divided into two major phenotypic
subsets according to the pattern of their cytokines, TH1 and TH2 (Mosmann
et al., 1986). TH1 cells secrete interleukin 2 (IL-2), interferon-y (IFN-y), and
lymphotoxin (LT). In contrast, the TH2 cells secrete IL-4, IL-5, IL-6, and IL10.

Both TH types express IL-3, granulocyte-macrophage

colony-

stimulating factor (GM-CSF, preproenkephalin (ppENK), tumor-necrosis
factor (TNF) and three members of the macrophage inflammatory protein
family (Cherwinski et al., 1987).
CD4+ T cells can serve as helper cells for both antibody synthesis and
cell mediated responses. The different cytokine patterns lead to very
different functions of T cells, and these properties have been extensively
reviewed (Mosmann and Coffman, 1989). They are involved in the activation
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of macrophages, delayed-type hypersensitivity (DTH), and stimulation of
the proliferation of both B lymphocytes and T lymphocytes. It is clear that
the help for B-cell antibody synthesis is provided primarily by TH2 cells.
TH2 cytokines such as IL-4, IL-5 and IL-6, stimulate various aspects of Bcell growth and differentiation. TH1 clones can also provide help for B-cell
antibody secretion by secreting IL-3. However, TH1 cells play a major role in
cell-mediated immune responses by producing IL-2 which can activate T
lymphocytes to proliferate.

Interferon-y which is a major macrophage

activating factor that can induce toxoplasmacidal activity in macrophages
and mononuclear cells is also synthesized by T H 1 cells.

It is very

interesting to immunologists who study infectious diseases that the TH1 and
TH2 cells can cross-regulate each other by the release of special cytokines.
IFN-y has suppressive effects on

TH2 cells, and IL-10 has suppressive

effects on TH1 cells(Cher & Mosmann, 1987; Cherwinski et al., 1987;
Fiorentino et al., 1989; Bacchetta et al., 1990; Abbas, et al., 1991; Scott &
Kaufman, 1991; Cox and Liew, 1992).
A number of studies have demonstrated that CD4+ T lymphocytes are
active participants in mechanisms t h a t modulate both enhancement and
resistance to infection with various parasitic organisms
Leishmania

sp., Trypanosoma

cruzi,

Schistosoma

Pneumocystis

carinii (reviewed by Sher and Coffman, 1992).

including

mansoni,

and

In murine

toxoplasmosis, CD4+ T cells participate in protection against death during
acute infection and are i m p o r t a n t modulators

of pathogenesis

of

toxoplasmic encephalitis in chronically infected animals (Araujo, 1991).
Many cells of the immune system are under CD4+ T cell control;
therefore, inhibition of the humoral and cell-mediated immune responses
and induction of tolerance to some nonreplicating antigens may be achieved
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by treatment of mice with a rat monoclonal antibody specific for mouse
CD4+ (GK1.5). Injection of GK1.5 followed by immunization of mice with a
nonreplicating antigen of T. cruzi

resulted in an almost

complete

abrogation of the antibody and cell-mediated immune responses to antigens
of t h e

parasite

even

when

immunomodulator saponin.

they

were

mixed

with

the

potent

Moreover, the injected and immunized mice

completely failed to develop resistance to a challenge infection with T. cruzi
blood-form trypomastigotes. It was also shown that treatment with GK1.5
effectively inactivated the capacity of CD4+ T cells to recognize T. gondii
antigens and induce development of humoral and cell-mediated immune
responses in spite of the continuous presence of parasite antigen provided by
multiplying organisms (Araujo, 1991).
Sadick and coworkers (1990), in studies with BALB/c mice susceptible
to t h e intracellular parasite Leishmania

major,

demonstrated

that

treatment with GK1.5 monoclonal antibody did not directly kill or prevent
IFN-y producing cells from proliferating but did greatly reduce the ability of
the mice to produce IFN-y.

This result suggests t h a t in the model with

BALB/c mice and L. major, IFN-y-producing cells may be dependent on a
critical subset of CD4+ T cells to become functional cells.

Experiments

which demonstrated that significantly less inflammation occurred in brains
of mice infected with T. gondii and treated with GK 1.5 may be explained by
a similar mechanism, since a major role for IFN-y in the pathogenesis of
toxoplasmic encephalitis has been recently demonstrated (Sadick et al.,
1990).
A mouse model system was developed and used by Araujo (1992) to
study the effects of in vivo depletion of CD4+ T cells and/or inhibition of the
protective activity of IFN-y

on the effectiveness of drug therapy for
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toxoplasmosis.

Infection of mice with a lethal inoculum of

Toxoplasma

gondii cysts followed by treatment with the hygroxynaphthoquinone 566c80
or with sulfadiazine result in 100% survival, whereas untreated controls
experienced 100% mortality.

Administration of anti-IFN-y

antiserum

resulted in early death of untreated mice and in 30% mortality in those
treated. Sulfadiazine and hydroxynapthoquinone 566c80 were unable to cure
toxoplasmosis when CD4 + T cells were depleted by injection of mAb to CD4+
T cells. These results indicate that successful treatment of toxoplasmosis
depends on the status of the immune system, particularly the status of CD4+
T cells.

These results also illustrate the crucial role t h a t a functional

immune system may play in enhancing the efficacy of therapeutic agents
against parasites (Araujo, 1992).
Cross-regulation of TH1 and TH2 responses during parasitic infection
Parasitic infection is frequently accompanied by a downregulation in
host cell-mediated immunity. Recent studies suggest that this modulation
of CD4+ T cells and effector cell function can at least in part be attributed to
the action of a set of inhibitory cytokines produced by T lymphocytes as well
as by a number of other cell types. The best characterized of these inhibitory
lymphokines are IL-4, IL-10 and TGF-b. Both IL-4 and IL-10 are produced
by the TH2 subset of CD4+ T cells but not TH1 cells.

The TH2 subset

dominates in many situations of chronic or exacerbated parasitic infection
and is thought to suppress TH1 function as a consequence of the crossregulatory activity of these two cytokines. This hypothesis is supported by
experiments demonstrating that mAb-mediated neutralization of IL-10
reverses suppressed IFN-y responses and/or disease susceptibility in mice
with parasitic infections. In vivo neutralization of TGF-b has been reported
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to increase host resistance to parasite challenge (Gajewski et al., 1989;
Mosmann et al., 1986; Mosmann & Coffman, 1989; Scott et al., 1989; Scott,
1991; Peltz, 1991).
Unlike the bacterial and viral infections which tend to be resolved
relatively quickly (cure or death), many parasitic infections persist for long
periods and involve high antigen loads. The immune system is stimulated
strongly and chronically, and a variety of extreme responses will be seen.
There are a number of parasites that provoke an extremely strong TH2-like
response involving not only the TH2 cytokines but also high IgE and
eosinophil levels. There are also some parasites t h a t induce a very strong
DTH response with the absence of significant antibody or IgE production. It
is now believed that subsets of CD4+ T lymphocytes play a key role for
determining which response will be aroused (Beaman et al., 1992; Sher et
al., 1992).
Studies in which mice have been treated with anti-IL-4 and anti-IL-5
in vivo have shown t h a t the high levels of parasite-specific antibody
(especially IgE) and also high eosinophil levels in
brasiliensis

Nippostrongylus

(Bb) infection are due to IL-4 and IL-5, respectively. When

splenic T cells, lung, or mesenteric lymph node T cells are obtained from
infected animals and restimulated with polyclonal stimuli in tissue culture,
very high levels of the TH-2 cytokines IL-4, IL-5, and IL-10 are produced;
often there is a reduction in the ability of these cells to produce IL-2 and IFNy. When anti-IL-10 antibody is added to the in vitro culture system during
t h e stimulation of normal mouse splenocytes, there is a moderate
enhancement of the amount of IFN-y secreted. However, if anti-IL-10
antibodies are added to the cultures from parasite-infected animals, there is
a greater increase in the amount of IFN-y produced, suggesting that the
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high levels of IL-10 produced during the culture period are suppressing the
synthesis of IFN-g in the same culture. (Sher et al., 1992; Sher et al., 1991;
Fiorentino et al., 1991a)
During infection by Schistosoma

mansoni, a strong immune response

develops after parasite production of eggs. The egg antigens induce a very
powerful TH2-like response involving high levels of IL-4, IL-5 and IL-10.
Antigen stimulation in culture does not induce significant levels of IFN-y
secretion. However, if anti-IL-10 antibodies are added to these cultures, high
levels of IFN-y secretion are observed, suggesting that the IL-10 produced
during the culture is able to substantially inhibit the synthesis of IFN-y in
the same culture, (reviewed by Mosmann et al., 1991)
Unanswered questions pertaining to CD4 + T cells in parasitic infection
CD4+ T cells may play the key role in the immune system in
regulating the immune response. It has been shown t h a t in T.

cruzi

infection both CD4+ and CD8+ T cells are necessary during the early acute
phase of infection but contribute less to immune resistance as the antibody
response builds. Stimulation of the T-cell compartment also may induce
responses which contribute to pathogenesis. (Tarleton, 1991a)
Several unanswered questions remain concerning

CD4+ T cells.

Which cell types mediate the initial decision of the direction of TH cell
differentiation? What is the nature of the signals that induce selective
differentiation? Even though several cytokines have already been implicated
in the differentiation process, it is very likely t h a t different antigen
presenting cells (APC) are also involved. Such APC subsets could directly
influence the type of TH cell obtained, or the choice could be regulated by
cytokines secreted by third-party cells such as mast cells, NK cells or other T
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cells. It is very likely that the mechanisms of this choice will be multiple,
redundant and substantially interregulated.
Because quantitative variations in cytokines exist between cells from
the same subset of CD4+ T cells, investigators have hypothesized that TH
cells might be further subdivided. Another interesting quantitative question
is whether T-cell activation is an "all-or-none" phenomenon, or whether
different amounts can be released in response to quantitatively or
qualitatively different signals. This question is particularly important
because of the suggestion of directional release of cytokines. TH cells, when
maximally stimulated, secrete sufficient amounts of cytokines(such as IL-3,
IL-4 and IL-5) to stimulate more than 1000 target cells; thus, directional
release would not be expected to be significant unless smaller amounts of
cytokine were secreted under some circumstances. (Tarleton, 1991a).
The

final

question is the possible existence of memory cells for

effector function as well as specificity. Recent evidence suggests that longterm memory TH cells may produce predominantly or exclusively IL-2
when first restimulated. Under many circumstances, it would be useful for
the memory response to reexpress the same set of effector functions as those
expressed during the primary response.

It is possible t h a t long-term

memory cells are in fact uncommitted, so that the differentiation to effector
phenotypes occurs under similar regulation to that of the primary response.
Alternatively, the memory TH population, although expressing only IL-2
when initially stimulated, nevertheless may still be committed to the
production of a particular set of cytokines that will be expressed on repeated
stimulation. (Mosmann et al., 1991)
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The suppression of immune responses dnringTrypanosoma
Trypanosoma

cruzi

is

the

etiologic

agent

cruzi

infection

of

American

Trypanosomiasis or Chagas' disease and it is believed to infect between 12-40
million people in endemic regions of Central and South America (Kuhn,
1981; Swendel & Gonzaga, 1993).
The protective immune response to T. cruzi infection in mice and in
humans is known to involve the combined effects of a number of different
immune mechanisms, including the production of antibodies, helper and
effector functions of CD4+ T cells, activity of CD8+ T cells, and the
production of cytokines. (Cunningham and Kuhn, 1980; Trischman, 1983;
Hontebeyrie-Joskowicz, 1991)
Although various effector mechanisms are induced to respond to
infection with T. cruzi,

a significant nonspecific suppression of both

humoral and cell-mediated responses also develops in infected mice
(Gonzalves da Costa et al., 1984; Plata, et al., 1987). Suppression of parasitespecific responses has also been demonstrated and is thought to reduce the
resistance of an infected host to T. cruzi (Coffman & Mosmann, 1991).
Tarleton and Kuhn (1985) used T. cruzi

conjugated to the hapten

trinitrophenyl (TNP; the conjugated preparation is designated TNP-TC) in
the Mishell-Dutton culture system to measure the direct plaque-forming cell
(DPFC) response of non-infected and T. cruzi- infected mice to TNP-TC. The
anti-hapten B-cell responses reflected the activity of carrier-specific T-helper
cells to T. cruzi.

The response of spleen cells from infected mice to TNP-TC

was not found to be significantly higher (and was often lower) than that of
normal

spleen cells.

These results suggest t h a t

parasite-specific

suppression of T-helper-cell activity could be occurring during infection.
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The addition of exogenous interleukin-2 (IL-2), or the replacement of
resident macrophages with normal macrophages in in vitro

assays,

increased the responsiveness of spleen cells from infected mice. From these
observations, it seems that the initial priming to T. cruzi during infection
may not be sufficient to expand the parasite-specific T-helper-cell population
and t h a t perhaps the same suppressor mechanisms which down-regulate
the reaction to heterologous antigens might also be suppressing the
response of T. cruzi-specific T-helper cells.(Tarleton and Kuhn, 1985)
Experimental observations strongly suggest that T cells control, at
least in part, the parasitemia and resistance of mice to acute infection.
Neonatally thymectomized or nu/nu mice present higher parasitemia and
less resistance to acute infection than do normal mice. In vivo treatments
with monocolonal antibodies against T cell surface markers indicate that
both CD4+ and CD8+ T cells may play a role in determining resistance in
the acute phase of infection by controlling parasitemia and antibody
production. In the acute phase, passive transfer of T. cruzi

specific T-cell

clones has provided protection against acute phase infection.(Cunningham
& Kuhn, 1980; Hontebeyrie-Joskowicz, 1991; Minoprio et al., 1989; Tarleton,
1990)
The role of CD4+ T lymphocytes inT. cruzi infection
As in other parasitic infection, the CD4+ T cell also plays a key
regulatory role in T. cruzi infection though the secretion of cytokines.
Interleukin-2 (IL-2) is the cytokine secreted by TH1 T lymphocytes. It
is a single polypeptide which has a molecular weight of approximately
15.5KD (Kuby, 1992). Interleukin-2 has been the focus of many studies on T.
cruzi infection both because of its central role as the primary T cell growth
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factor and because its production is severely suppressed during the acute
phase of infection. Exogenous IL-2 can alter the immune responsiveness of
lymphocytes from T. cruzi-infected
but

cannot

completely

mice as well as the course of infection

overcome immunosuppression

or r e s u l t

in

parasitological cure in the mouse model of T. cruzi infection. The cellular
and molecular mechanisms of IL-2 suppression in T. cruzi infection are not
yet clear. (Tarleton, 1991b; Peltz, 1991)
IL-2 production in general is known to be regulated primarily at the
transcriptional level, and the correlation of depressed IL-2 production with
low to absent IL-2 mRNA in mitogen-stimulated T cells from T. cruziinfected mice suggests that this is the probable level of regulation in T. cruzi
infection (Tarleton, 1991b).
Interferon-y (IFN-y) is also secreted by TH1 cells, and it has been
identified as the major macrophage activating factor. This cytokine is also
produced by CD8+ T lymphocytes, but in significantly smaller quantities
compared with CD4+ T lymphocytes ( Mosmann & Moore,

1991).

Surprisingly, it was found that the major producers of IFN-y in the spleens
of T. cruzi-infected mice are Thy-1 bearing CD4- CD8- cells. The TH1 cells in
T. cruzi- infected mice are suppressed with respect to IL-2 production and
do not contribute to the abundant production of IFN-y. (Tarleton, 1991b)
During T. cruzi

infection, another dramatic change in cytokine

production in mice is the elevated level of IFN-y.

Throughout T. cruzi-

infection, the ability of splenic T cells to make IFN-y remains at or above
t h a t of spleen cells from normal mice.

In addition, spleen cells from T.

cruzi -infected mice produce IFN-y in response to parasite antigens as well
as mitogens. Serum levels of IFN-y are also high as are IFN-y mRNA levels
and spontaneous IFN-y production in unstimulated spleen cells from
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acutely infected mice. Serum levels of IFN-y drop significantly after 18-20
days of infection, at the time when IL-2 production is minimal. It seems that
the IFN-y is significantly affected by IL-2 since the mice treated with
exogenous IL-2 have obviously enhanced IFN-y levels. The macrophages
activated by IFN-y treatment are able to efficiently kill or inhibit the growth
of intracellular forms of both parasites in vitro

and in vivo, and the

production of nitrous oxide has been shown to be important for these effects
(Tarleton, 1991b; Sher et al., 1992; Scott, 1991).
Interleukin-4 is primarily secreted by TH2 CD4+ T cells, but it is also
secreted by mast cells and basophils.
immune system.

IL-4 has multiple functions in the

It can induce the switching of B cells to IgE secretion.

This effect is mediated at the DNA level. IL-4 induces the transcription of
the e constant region and subsequently the recombination of the VDJ region
from the m to the e constant region. IL-4 also induces switching to IgGl
production(Gajewski et al., 1989; Sadick et al., 1990; Mosmann et al. 1991).
In Trypanosoma

cruzi infection, IL-4 has been potential B-cell stimulating

activity as do IL-5 and IL-6. Most research has focused on the ability of IL-4
to play a role in the cross-regulation of TH1 and TH2 responses during
parasitic infection. The major effect for down-regulation of cell mediated
immunity is that IL-4 can suppress the differentiation of TH1 and inhibit the
activation of macrophages (Sher et al., 1992).
IL-10 has been isolated from TH2 culture supernatants based upon its
activity in inhibiting the secretion of cytokines by TH1 cells when stimulated
with spleen cells plus antigen. IL-10 is now known to exert a direct effect on
antigen-presenting cell in inhibiting the antigen presentation to TH1 cells.
The native molecular weight of IL-10 is approximately 16 to 20 KD, and it
often appears as a homodimer (Mosmann et al., 1991).
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With the availability of recombinant IL-10, many other functions have
also been discovered.

These activities are similar to those of IL-4.

Specifically, it can inhibit IFN-y synthesis by TH1 cells. Both IL-4 and IL-10
also inhibit the synthesis of IL-1, IL-6 and TNF-a by macrophages. In a
study in which spleen cells were used as antigen-presenting cells, it was
found that IL-10 was able to significantly inhibit the synthesis of IFN-y by
various CD8+ clones. (Mosmann et al, 1991; Sher et al., 1992; Sher et al.,
1991; Fiorentino et al, 1991b)
Coffman & Mosmann (1991) found t h a t IL-10 does not play a
significant regulatory role in Leishmaniasis.

However, in T.

cruzi

infection, IL-10 has an important regulatory effect. Anti-IL-10 treatments
rendered susceptible mice resistant to T. cruzi. A similar down-regulation
of cell mediated immunity during infection with T. gondii

has also been

found.
In addition to the above cytokines, there is one other important
cytokine that should be mentioned: Transforming Growth Factor-b (TGF-b).
This cytokine is secreted by platelets, macrophages and T and B
lymphocytes. TGF-b has a broad anti-proliferative effect on both B and T cells
but can apparently influence CD4 + T cell responses by inducing the
development of memory cells from resting precursor populations. (Silva et
al., 1991; Sher et al, 1992)
The therapeutic effects of elevated temperature during parasitic infection
The value of fever as a clinical sign has been widely reported since
ancient time, and in the past the presence of fever was often regarded as
favorable to the patient's survival. Artificial fever was used to combat
intractable chronic infections in the 1920s. Today it is recognized that fever
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is a regulated rise in body temperature under central nervous system
control.

The central nervous system adjustments t h a t lead to fever are

stimulated by a pyrogenic polypeptide released from activated host blood or
tissue cells such as macrophages. It is known t h a t the host-derived
mediator of fever is one of the many

activities of IL-1. Gene sequencing

indicates that what we call IL-1 is probably not a single gene product but
several distinct polypeptides derived from a multi-gene family. (Duff, 1985)
The association of fever with the immune response through the
shared endogenous mediator, IL-1, led to the question of how these two
effects of IL-1, a brain-mediated elevation in temperature and augmentation
of lymphocyte activation, might be related.

It was found t h a t elevated

temperature has profound effects on the immune system, particularly by
increasing T-cell proliferation rates, interleukin-l(IL-l)-driven secretion of
IL-2, and primary antibody responses to T-dependent antigens. To test if the
pyrogenic action of IL-1 created an optimal temperature environment for its
own lymphostimulatory action, murine thymocytes were exposed to IL-1
both at 37°C and at 39°C. T-cell proliferation was measured after three-days
in culture and was found to be greatly increased at the higher temperature
(often as much as tenfold). This thermal enhancement of IL-1 driven T-cell
proliferation did not seem a general property of lymphocyte mitogensis,
since B cells responded less well to the polyclonal mitogen lipopolysacharide
at the higher temperature. It was confirmed in vivo that the IL-1 used in
these experiments was pyrogenic for the mouse strain. Average mouse body
temperature rose from 37.2°C to 38.59°C following intravenous injection of
IL-1. (Hanson et al., 1983; Gerne* al., 1991)
Studies have been performed to test the effect of febrile temperature on
the primary, in vitro, humoral immune response of murine spleen cells to
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sheep red blood cells.

In this system, a whole population of spleen cells

responds to the antigenic stimulus by generating activated B cells t h a t
secrete specific antibody.

This phenomenon occurs under T-cell control

during a five-day culture. Initial experiments showed that the number of
antibody-producing B cells obtained from these culture could be increased by
two- to twenty-fold by exposure of the spleen cells to febrile temperatures.
Furthermore, optimal effects occurred with exposure to hyperthermia
restricted to the first 24 hours of culture. In contrast, when the cells were
held at 37°C for the first 48 hours and then exposed to hyperthermia for the
subsequent three days, no thermal augmentation was detected.

When

individual populations of lymphocytes were exposed to hyperthermia and
then added back to reconstitute the whole spleen cell culture, it was shown
that the generation of T-helper cells was greatly increased at the higher
temperature, while B cell function was not influenced. (Duff, 1985)
The above results suggest that fever may have survival value through
increased immune responsiveness at higher temperatures.

However, it is

i m p o r t a n t to stress t h a t the n a t u r a l killer cell activity of h u m a n
mononuclear cells incubated for 18 hours at 39°C was significantly reduced,
as was the production of IL-1, IL-2, and Granulocyte-macrophage colonystimulating factor (GMCS) (Lederman et al., 1987).
Therapeutic effects of elevated environmental temperature during T. cruzi
infection
The therapeutic effect of increased environmental temperature on T.
cruzi infection in mammals has been described by several investigators;
however, the precise mechanisms responsible for this phenomenon have not
been elucidated.
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In these early studies, mice or rats held at higher temperatures (35 to
37°C) experienced less intense infections with T. cruzi

as indicated by

decreased parasitemias and increased longevity (Marinkelle & Rodriguez,
1968).

Anderson and Kuhn (1989) provided f u r t h e r evidence for the

therapeutic effects of increased environmental temperature on T. cruzi
infection when they reported that C3H mice infected with T cruzi

and

maintained at 36°C experienced both lower parasitemia levels and greater
longevity than did infected mice held at room temperature. The peak mean
parasitemia of infected mice held at room temperature was 19- to 20-fold
greater than that of infected mice held at 36°C. In addition, all infected mice
maintained at room temperature died by day 38, whereas infected mice
maintained at 36°C survived throughout the course of the experiment.
Possible effects of increased temperature on parasites may include
morphological changes or change in the production of heat-inducible
parasite proteins. However, Dimock et al (1991) demonstrated that elevated
temperature does not affect the parasites directly. In this experiment, mice
held

at

36°C

were

cyclophosphamide.

treated

with

the

immunosuppressive

agent

Peak mean parasitemia levels were 8.6-fold greater

t h a n those of non-cyclophosphamide-treated mice held at 36°C, and the
cyclophosphamide-treated mice all died by day 31 of infection. In a similar
study, Otieno (1972 and 1973) also found that cyclophosphamide treatment of
Trypanosoma

brucei -infected mice held at 35°C abrogated the beneficial

effects of elevated environmental temperature.

Further support for the

conclusion that the positive effects of elevated environmental temperature
are not due to detrimental effects of temperature on the parasite was also
provided in a report by Dimock et al (1991). These investigators found that
protection observed in T. cruzi - infected mice held at 36°C could be conferred
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on infected mice held at room t e m p e r a t u r e by passive t r a n s f e r of
hyperimmune sera.
The ability of T. cruzi - infected mice to produce antibody to
heterologous antigen has been reported to be enhanced at elevated
temperatures both in vitro and in vivo in T. cruzi

-infected mice.

The

parasite-specific response of T-helper cells in T. cruzi -infected mice held at
36°C is also enhanced (Dimock et al., 1991). However, Dimock et al (1991)
reported that production of parasite-specific antibodies is not enhanced early
in infection. By examining the production of parasite-specific antibodies
during the acute phase of infection in C3HeB/FeJ mice held at 36°C and at
room temperature, the authors found that the reactivity and diversity of
anti-T. cruzi

antibodies were greater in mice held at room temperature

t h a n in those held at 36°C.

However, the levels of parasite-specific

antibodies in infected mice held at 36°C could be elevated to levels which
surpassed those of infected mice held at room temperature in both reactivity
and diversity following injection of mice with culture forms of T.

cruzi.

Further analysis of the humoral response to T. cruzi in mice maintained at
elevated environmental temperature showed that the low levels of parasitespecific antibodies observed in infected mice held at 36°C may be due to
lowered antigen exposure as a result of lower parasitemia levels. In their
experiments, infected mice held at 36°C were capable of mounting a
stronger anti-T. cruzi

antibody response than infected mice held at room

temperature. Injection of 10 8 CFs greatly increased both the reactivity and
diversity of anti-T. cruzi antibodies produced in mice held at 36°C. By using
enzyme-linked immunosorbent assay and immunoblot analysis, Dimock et
al (1992) found that both parasite-specific antibody levels and numbers of
antigens identified increased during infection in mice held at 36°C, with the
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greatest reactivity measured in sera from mice t h a t had

resolved

parasitemias.
Heat shock of culture forms of T. cruzi resulted in production of heat
inducible antigens, but there were no strong differences in the antigens
recognized by sera from mice held at room t e m p e r a t u r e and those
recognized by sera from mice held at 36°C. However, immunoblot analysis
using blood-form trypomastigote antigens identified a band of approximated
61 KD produced by trypomastigotes in mice held at 36°C t h a t was strongly
detected by sera from mice held at 36°C (Dimock et al., 1992).
Elevated temperature is known to have profound effects on the
immune system particularly by increasing T cell proliferation rates,
enhancing interleukin-l(IL-l) driven secretion of interleukin-2 (IL-2), and
enhancement of the primary antibody response to T-dependent antigen
(Gern et al., 1991). Recently, elevated temperature has also been shown to be
a powerful promoter of IL-1 and IL-2 transcription.

However, little

information is available concerning the precise mechanisms by which
elevated temperature exerts its effects upon the immune system.
From the evidence described above, it is clear t h a t

elevated

temperature has profound effects on the immune system. In the present
study, the role of CD4+ T cells in the immune response to T. cruzi in mice
held at elevated environmental temperature was examined by depletion of
CD4+ T cells with an murine anti-CD4 monoclonal antibody.

MATERIALS AND METHODS
Parasites
The parasites used in this study were of the Brazil strain of T. cruzi.
These parasites were maintained in the laboratory as stock infections in
C3HeB/FeJ mice (BFT, blood-form trypomastigotes). Mice were infected
intraperitoneally with 10 3 BFTs in 0.2ml of Dulbecco's phosphate-buffered
saline (DPBS; GIBCO Laboratories, Grand Island, New York).
Mice
Female C3HeB/FeJ mice (Jackson Laboratory, Bar Harbor, Maine) 810 weeks old at the time of infection were used in this study. After infection,
mice were maintained at room t e m p e r a t u r e or were placed in an
environmental chamber and held at 36°C. Age-matched groups of noninfected mice were also held at either room temperature or 36°C for the
course of experiments. Food and water were provided ad libitum. All mice
were maintained and used in accordance with local IACUC guidelines.
Cell Cultures
The GK1.5 rat hybridoma cell line was purchased from the American
Type Culture Collection (ATCC; Rockville, MD) and maintained in RPMI1640 (Sigma Chemical Co., St. Louis, MO) adjusted to p H 7.2 with 25mM
Hepes and supplemented with penicillin G (100 units/ml), streptromycin
(lOOmg/ml) (incomplete RPMI-1640) and 20% fetal bovine serum (FBS)
(complete RPMI-1640). Cells were grown in 75 cm 2 flasks (Corning Glass
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Co., Corning, NY) and were maintained at 37°C in a 5% CO2 atmosphere at
high relative humidity.
Purification Of Anti-CD4 Monoclonal Antibody
Ammonium Sulfate Precipitation
Hybridoma (GK1.5) cells were removed from culture supernatants by
centrifugation at 1300xg for 10 minutes. The supernatants were collected
and then placed in a large beaker on ice. A 30 cc syringe was used to slowly
add saturated ammonium sulfate solution to the beaker dropwise while the
solution was being stirred. The solution was t h e n incubated in the
refrigerator overnight. Following the overnight incubation, the solution was
centrifuged at 45,000xg for 1 hour. Supernatant was discarded and the pellet
was dissolved in 5ml of phosphate buffered saline (PBS). The dissolved
precipitate was then transfered to dialysis tubing. The antibody solution was
then dialyzed against a large volume of PBS 24 to 48 hour at 4°C. The buffer
was changed at least once during dialysis.
Purification of Rat IgG Using Protein G Affinity Chromatography
Immobilized protein G gel (BioRad, Richmond, CA) was carefully
packed into a column according to manufacturer's instructions. The
column was then equilibrated with 10 column volumes of binding buffer (0.1
M sodium acetate, pH 5.0). The antibody sample was diluted 10:1 with
binding buffer and then applied to the equilibrated column. The sample was
allowed to flow completely into the gel. The protein G column was then
washed with 6-10 column volumes of the binding buffer. The bound IgG was
eluted with 3-5 volumes of the elution buffer (50mM glycine HC1 buffer, pH
2.5-2.8). The eluate was collected in 1ml fractions. The pH of the protein
fractions was returned to neutrality by the addition of 10ml of 500mM Tris
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buffer, pH 7.6 to each 1ml fraction. The concentration of the antibody was
determined by the BioRad modification of the Bradford technique (Bradford,
1976).
In vivo Depletion of CD4-Specific T cells
The in vivo depletion of CD4+ T cells was performed according to the
following technique which was adapted from the method of Kruisbeek (1991).
Purified anti-CD4 monoclonal antibody from GK1.5 hybridoma culture
supernatants (380mg) was injected intraperitoneally into individual 8 week
old mice for three consecutive days. Control mice were injected with an
equivalent concentration of normal rat IgG. On day 6, spleen cells from one
mouse from each group were analyzed by indirect immunofluorescence
followed by direct cell counting with a hemocytometer on an Olympus BH-2RF1 fluorescence microscope to determine if satisfactory depletion (>95%)
had been obtained. (The total number of cells and the number of positive
cells in four large squares of the hemocytometer was counted and the
average number of positive cells in one large square was calculated). When
antibody treatment was judged to have been successful, the mice were
infected with 10 3 blood-form trypomastigotes (BFTs) of T. cruzi and were
immediately placed at either room temperature or 36°C as described above.
To maintain the depleted condition, remaining mice were given 380mg
injections of monoclonal antibody every 6-7 days. Two weeks following
infection, the antibody injections were discontinued. Two mice from each
group were killed on day 31 of infection to observe the effect of depletion
during T. cruzi infection.
The effect of the depletion of

CD4+ T cells on the remaining

population of CD8+ T cells during T. cruzi infection was also determined by
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comparing the percentage of CD8+ T cells before depletion to the percentage
following depletion (30 days after T. cruzi infection). In addition, the effect of
elevated temperature on CD4+ T cell and CD8+ T cell populations following
CD4+ T cell depletion was also measured.
Indirect Immunoflourescence Assay
Preparation of Spleen Cells
The spleens were surgically removed and placed into small petri
dishes containing RPMI-1640. The spleens were minced with large forceps
and the resulting cell suspensions were drawn up into a 5cc syringe
through 22 gauge needle and expelled into a 15cc tube through a 26 gauge
needle. Erythrocytes were lysed by hypotonic shock and spleen cells were
counted with the use of a hemocytometer. The cells were then diluted to a
final density of l¥10 7 /ml in complete RPMI-1640.
Indirect Immunofluorescence
A 100ml aliquot of the spleen cell suspension was placed into a
microcentrifuge tube on ice. Twenty-five ml (~0.6mg/ml) of purified antiCD4+ monoclonal antibody or normal rat IgG (Sigma) were added to the
contents of the the tube and the tube was mixed well. The cells were
incubated for 30 min on ice with frequent agitation. The cells were
centrifuged at 8000xg for 1 minute in a refrigerated microcentrifuge, and
the supernatant was carefully removed. The cell suspension was washed
three times with 500ml incomplete RPMI-1640. The cells were resuspended
inlOOml cold incomplete RPMI-1640 and 5 ml of goat anti-Rat IgG labeled
with fluorescein isothiocyanate (FITC) was added to the tube. The contents
of the tube were mixed well and incubated on ice for 30 minutes. The cells
were centrifuged for 1 min. at 8000x g. The supernatant was removed, and
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the cells were washed 3 times in 500ml cold incomplete RPMI-1640. After
the final wash, the cells were resuspended in 100ml of PBS and the results
analyzed with the use of an Olympus BH-2-RF1 fluorescent microscope.
Parasitemia and Longevity
Parasitemia levels were monitored in all infected mice beginning at
day 12 and continuing every 3 days throughout the course of infection. A 4ml
sample of blood was taken from the tail, and a dilution of the sample in PBS
was counted by use of a hemecytometer. In addition, mice were monitored
daily to determine levels of mortality and morbidity.
Experimental Design
The mice were divided into 8 groups according to different
experimental treatment. Group 1, 2, and 5 had 6 mice in each group. Group
3, 4, 7, and 8 had 4 mice in each group. The specific experimental treatment
of each group is shown in Table 1.
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Table 1: Experimental Treatment for Each Group of Mice
CD4+ T cell
Group 1
Group 2
Group 3
Group 4
Group 5
Group 6
Group 7
Group 8

Non-depleted

Temperature
Room
Room
Room
Room

Depleted
Non-depleted
Depleted
Non-depleted

36°C
36°C
36°C
36°C

Depleted
Non-depleted
Depleted

Infection
T. cruzi
T. cruzi
Normal
Normal
T. cruzi
T. cruzi
Normal
Normal

RESULTS
The effects of temperature on parasitemia
The parasitemia levels which were determined for all groups of infected
mice are shown in Figures 1 through 4. In comparing the parasitemias of mice
held at 36°C to those held at room temperature, it is clear that maintenance at 36°C
results in a significant delay in the appearance of blood-form trypomastigotes. The
parasites appear on day 14 of infection in CD4 depleted mice maintained at room
temperature and on day 25 in CD4 depleted mice maintained at 36°C. In the CD4
non-depleted mice, parasites appeared on day 18 in mice held at room temperature
as compared to day 29 in mice maintained at 36°C.
In both CD4 depleted and CD4 non-depleted mice, the peaks of parasitemia
were markedly different between mice maintained at room temperature and 36°C.
The highest parasitemia levels in room temperature CD4 depleted mice were 1.84
xlO 7 BFT/ml as compared to 9.13 xlO 6 BFT/ml in CD4 depleted mice maintained at
36°C. In CD4 non-depleted mice, the highest parasitemia levels were 1.68 x 107
BFT/ ml in room temperature CD4 non-depleted mice and 4.37 xlO 6 BFT/ml in CD4
non-depleted mice maintained at 36°C.

Obviously, elevated temperature can

significantly depress the parasitemia in mice infected with T. cruzi.

Figure 1. The parasitemia in CD4+ T cell depleted mice maintained at room
temperature (RTLD). Depletion was maintained for 2 weeks of infection.
Mouse 3 and mouse 5 were killed on day 31 of infection for spleen cell assay.
Mouse 4 died on day 30. Mouse 2, 6, and 7 died on day 33 of infection. Mouse
1 died on day 35 of infection.
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Figure 2. Parasitemia in CD4+ T cell non-depleted mice maintained at
room temperature ( RTI/ND). Mouse 2 and mouse 4 were killed on day 31 of
infection for spleen cell assay. Mouse 5 and 7 died on day 33 of infection.
Mouse 1 died on day 36 of infection. Mouse 3 died on day 39 of infection.
Mouse 6 died on day 43 of infection.
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Figure 3. Parasitemia in CD4+ T cell depleted mice maintained at 36°C
(36I/D). Depletion was maintained for two weeks of infection. Mouse 1 and
mouse 2 were killed for spleen cell assay on day 31 of infection. Mouse 3 died
on day 46 of infection and mouse 4 died on day 52 of infection. Mouse 5
survive through day 52 of infection at which time the experiment was
terminated.
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Figure 4. Parasitemia in CD4+ T cell non-depleted mice maintained at 36°C
(36I/ND). Mouse 3 and mouse 6 were killed on day 31 of infection for spleen
cell assay. Other mice survived through day 52 of infection at which time
the experiment was terminated.
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Effects of CD4+ T cell depletion on parasitemia in mice maintained at 36°C
or room temperature
In Figure 1 through Figure 4, it can be seen that the depletion of CD4
+ T cells can slightly enhance the appearance of blood-form trypomastigotes
of T. cruzi in mice held at room temperature or 36°C. In the two groups of
mice maintained at room temperature, the parasites appeared on day 14 of
infection in CD4 depleted mice

and on day 18 of infection in CD4 non-

depleted mice (Figure 1 & Figure 2). In mice maintained at 36°C, parasites
appeared on day 25 in CD4 depleted mice and day 29 in CD4 non-depleted
mice (Figure 3 & Figure 4).
Depletion of CD4 + T cells also resulted in shifts in average
parasitemia value in mice at both temperatures.

The peaks of the mean

parasitemia in different mice group are as follows: 1.84 X 107 in CD4+ T cell
depleted mice maintained at room temperature; 8.46 XlO 6 in CD4+ T cell
non-depleted mice maintained at room temperature; 7.88 X 106 in CD4+ T
cell depleted mice maintained at 36°C; 1.7 X 106 in CD4+ T cell non-depleted
mice maintained at 36°C (Figure 5). The observed peak parasitemia values
from different group were as follows: in room temperature mice, the peak
parasitemia in CD4 depleted mice was 1.84 X 107 BFT/ml as compared to
1.68 X 107 BFT/ml in CD4 non-depleted mice (Figure 1 & Figure 2). In mice
maintained at 36°C, the peak parasitemia was 9.13 XlO 6 BFT/ml in CD4+ T
cell depleted groups of mice as compared to 4.37 X 106 BFT/ml in CD4+ T cell
non-depleted mice (Figure 3 & Figure 4).

Figure 5. Comparison of the mean parasitemia values. RTI/D refers to CD4
depleted mice infected with T. cruzi maintained at room temperature.
RTI/ND refers to CD4 non-depleted mice infected with T. cruzi maintained
at room temperature. 36I/D refers to CD4 depleted mice infected with T.
cruzi maintained at 36°C. 36I/ND refers to CD4 non-depleted mice infected
with T. cruzi maintained at 36°C.
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Effects of CD4+ T cell depletion on mortality in Mice infected with T. cruzi
Figure 6 shows the mortality data for all four groups of mice infected
with T. cruzi as compared to non-infected controls. The CD4 depleted mice
maintained at room temperature (RTI/D) began to die on day 30 of infection,
and the last mouse died on day 35 of infection. The CD4 non-depleted mice
maintained at room temperature (RTI/ND) began to die on day 33 of
infection, and the last mouse died on day 43. CD4 depleted mice maintained
at 36°C (36I/D) began to die on day 46 of infection, and one mouse survived
until day 52 of infection. The CD4 non-depleted mice (36I/ND) maintained at
36°C showed 100% survival through day 50 of infection.
The results demonstrated that the depletion of CD4+ T cells can shorten the
life span of infected mice. The life span of CD4 depleted mice held at room
temperature (RTI/D) was 32.6 ± 1.51 days as compared to 36.8 ± 4.26 in CD4
non-depleted mice at room temperature (RTI/ND). The life span of CD4
depleted mice maintained at 36°C (36I/D) was 48 ± 6.6 days. The CD4 nondepleted mice maintained at 36°C did begin to die at day 55 of infection. The
precise explanation for this result is unknown but may be due to the
significant wasting which was observed in the mice maintained at 36°C.
Mortality in this group was monitored, and the mean life span of CD4 nondepleted mice maintained at 36°C (36I/ND) was 68 ± 3.1 days.

Figure 6. Effect of CD4+ T cell depletion on mortality. Controls refer to noninfected mice maintained at 36°C or room temperature. RTI/D refers to
CD4 depleted mice infected with T. cruzi maintained at room temperature.
RTI/ND refers to CD4 non-depleted mice infected with T. cruzi maintained
at room temperature. 36I/D refers to CD4 depleted mice infected with T.
cruzi maintained at 36°C. 36I/ND refers to CD4 non-depleted mice infected
with T. cruzi maintained at 36°C.
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Results of Depletion Assays
A depletion assay was performed after the three injections of anti-CD4
monoclonal

antibody.

The depletion

results

immunofluorescence are shown in Figure 7.

obtained

by

indirect

A comparison of the

percentage of CD4+ T cells in mice injected with anti-CD4 monoclonal
antibody to untreated normal mice indicated t h a t > 95% depletion was
achieved.
Once 95% depletion was achieved, mice were divided into 8 groups.
Mice in four of these groups were infected with T. cruzi.

Two weeks post-

infection, anti-CD4 monoclonal antibody treatment and normal rat IgG
treatment were stopped, allowing the CD4+ T cells to gradually replenish.
Thirty-one days after infection, a second spleen cell assay was performed on
two mice from each group. The results are shown in Table 2, and Figure 8.
In this assay, it was found that elevated temperature enhanced the rate of
replenishment of CD4+ T cells without resulting in a change the percentage
of CD8+ T cells.
Furthermore, it was found t h a t the percentage of CD4+ T cells in
infected mice maintained at 36°C (36I/D) was higher t h a n in mice
maintained at room temperature (RTI/D). There were 25.63% CD4+ cells in
36°C mice as compared to 14.67% CD4+ T cells in room temperature mice.
In non-infected mice, the percentage of CD4+ T cells in CD4 depleted
mice maintained at 36°C also was higher than in mice maintained at room
temperature (27.86% CD4 positive cells in 36°C mice; 17.47% CD4 positive
cells in room temperature mice). (Refer to groups RTNI/D & 36NI/D in Table
2 and Figure 8)
It was found that the percentage of CD4 + T cells in CD4 non-depleted
mice was very similar in infected mice maintained at 36°C and in infected
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mice maintained at room temperature (Refer to groups RTI/ND & 36I/ND in
Table 2 and Figure 8).
Infection also appeared to stimulate the recovery of CD4+ T cells. In
all group comparisons, (group RTI/D vs group RTNI/D and group 36I/D vs
group 36NI/D) CD4+ T cells in infected mice recovered faster than CD4+ T
cells in non-infected mice at both temperatures.
The CD8+ T cell population was apparently not changed by CD4
depletion. In addition, there was no evidence that elevated temperature had
an influence on the percentage of CD8+ T cells in experimental mice.

Table 2. Spleen Cell Assay.
Group 1(RTI/D): CD4 depleted mice infected with T. cruzi maintained at
room temperature.
Group 2(RTI/ND): CD4 non-depleted mice infected with T. cruzi
maintained at room temperature.
Group 3(RTNI/D): CD4 depleted mice non-infected maintained at room
temperature.
Group 4(RTNI/ND): CD4 non-depleted and non-infected mice maintained at
room temperature.
Group 5(36I/D): CD4 depleted Mice infected with T. cruzi maintained at
36°C.
Group 6(36I/ND): CD4 non-depleted mice infected with T. cruzi maintained
at 36°C.
Group 7(36NI/D): CD4 depleted mice non-infected maintained at 36°C.
Group 8(36NI/ND): CD4 non-depleted and non-infected mice maintained at
36°C.
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Table 2. Spleen Cell Assay.

Group
Group
Group
Group

1
2
3
4

(RTI/D)
(RTI/ND)
(RTNI/D)
(RTNI/ND)

CD4+ T cell (%)
10.32
26.05
11.94

CD8+ T cell (%)
16.6
15.815

26.435

19.91
19.91

Group 5 (36I/D)

19.765

25.925

Group 6 (36I/ND)
Group 7 (36NI/D)
Group 8 (36NI/ND)

20.835
19.71
19.685

16.8
17.955
16.63

Figure 7. Spleen T cell assay after injection with anti-CD4 antibody. A
comparison of the percentage of CD4+ T cells in mice injected with antiCD4 antibody and in normal mice indicates approximately 95% depletion in
treated mice. The percentage of CD4+ T cells was determined by an indirect
immunofluorescence assay followed by direct cell counting with a
hemecytometer on an Olympus BH-2-RF1 fluorescence microscope.

36

«
©

30

-r

25

--

•

Mice Injected With
Anti-CD4 Antibody

•

Normal Mice

O
c

C
QD) 2 0
Q.
(0
os

o
I- 1 5 - -

a>

o>

5ra 1 0
c

0u
a>

a.

5

--

CD4+ T cell

CD8+ T cell

Figure 8. Analysis of T cell subpopulations by indirect
immunofluorescence. RTI/D refers to CD4 depleted mice infected with T.
cruzi maintained at room temperature. RTI/ND refers to CD4 non-depleted
mice infected with T. cruzi maintained at room temperature. RTNI/D
refers to CD4 depleted mice non-infected maintained at room temperature.
RTNI/ND refers to CD4 non-depleted and non-infected mice maintained at
room temperature. 36I/D refers to CD4 depleted mice infected with T. cruzi
maintained at 36°C. 36I/ND refers to CD4 non-depleted mice infected with
T. cruzi maintained at 36°C. 36NI/D refers to CD4 depleted mice noninfected maintained at 36°C. 36NI/ND refers to CD4 non-depleted and noninfected mice maintained at 36°C. Percentage refers to % of total spleen
cells.

Percentage

Of

Positive

Cells

(%)

H O
O
O
CD
=

+

H O
oCD O
CO
=

+

B

ID H

CO
CD

CO

Z

o
z

CO
CD

z

o

o

—

^^

Z

CO
O
—

o

B

•

33

33

33

Z

z
-

H

—I

—I

•
33

H

— —
z
o

o

U)
-J

DISCUSSION
The results of this study demonstrate that elevated temperature can
significantly delay the appearance of trypomastigote stages of T. cruzi in the
bloodstream and can decrease parasitemia levels and increase longevity in
infected mice.

These results confirm and extend previous reports t h a t

elevated environmental temperature can increase the immunity of the
murine host infected with T. cruzi (Anderson & Kuhn, 1989).
In a previous study, it was demonstrated t h a t maintenance of T.
cruzi -infected C3HeB/FeJ mice at 36°C not only increased longevity and
decreased parasitemia but also significantly enhanced both parasite-specific
and nonspecific immune responses. Whereas immunosuppression during
experimental Chagas' disease can be overcome to some degree by a variety of
means, neither the mechanisms responsible for immunosuppression nor
those responsible for overcoming suppression are clearly understood
(Anderson and Kuhn, 1989). Dimock et al (1991) found that C3H mice held at
room temperature developed high levels of parasite-specific antibodies and
died, whereas mice held at 36°C developed only low levels of anti-T . cruzi
antibodies by day 35 of infection yet survived infection. Moreover, by day 35
of infection (just prior to death in mice held at
temperature) there were no parasite antigens recognized by sera from mice
held at 36°C that were not also identified by sera from mice held at room
temperature.

It

was

concluded

in

this

study

that

parasite-
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specific antibodies do not play a significant role in protective immunity
during the early stages of infection. In the same study, it was found that Thelper-cell responses to T. cruzi were also enhanced. It is possible that the
survival of mice held at 36°C during the acute phase of infection may be
attributable to cell-mediated responses.

Results from the present study

show t h a t CD4+ T cells are required for the protective effect of elevated
temperature in T. cruzi infected mice. The in vivo depletion of CD4 + T cells
advanced the onset of parasitemia approximately 4 days in mice maintained
at room temperature or 36°C. However, in both CD4 depleted mice and CD4
non-depleted mice, maintenance at elevated temperature significantly
delayed the appearance of parasites. This result suggests t h a t elevated
temperature does have some effect upon the parasite which is independent
of the activity of CD4+ T cells.

Because CD4+ T cells play a central

regulatory function in the immune system, few functional protective
immune responses should remain after CD4+ T cells have been destroyed.
In the present study elevated temperature still exerted some protective
effects even after the depletion of CD4+ T cells. The recovery of CD4+ T cells
during infection may be part of the explanation, but it is still clear that other
components of the immune system must contribute to this phenomenon
through unknown pathways.
Elevated temperature greatly decreased the parasitemia levels in
infected mice, but the depletion of CD4+ T cells resulted in slightly increased
parasitemia levels in mice held at room temperature or 36°C, providing
further evidence that the beneficial effect of elevated temperature is to some
degree CD4 + T cell independent.
Elevated temperature also significantly delayed mortality in infected
mice. The CD4 depleted mice maintained at 36°C died approximately 12 days
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later t h a n CD4 depleted mice held at room temperature. All CD4 nondepleted mice held at room temperature died by day 46 of infection while CD4
non-depleted mice at 36°C maintained 100% survival until 52 days postinfection. From these mortality data, it can be hypothesized that CD4+ T
cells play an important protective role in the early stages of T.

cruzi

infection. Once CD4+ T cells were depleted, the protective immune response
at elevated temperature was disrupted. Even when the CD4+ T cells were
allowed to recover at 2 weeks post infection, the mice maintained at elevated
temperature still died by day 46 of infection. Further studies are needed to
determine what window of time is crucial for mice to establish and
maintain a protective response against the parasite.
The results of the present study suggest the following conclusions: 1)
Results confirm previous studies demonstrating that elevated temperature
increases the resistance of mice to T. cruzi. 2) The CD4+ T cell is necessary
to allow mice to establish and to maintain this temperature related
resistance to T. cruzi. 3) Enhanced resistance to T. cruzi

at elevated

temperature also involves CD4+ T cell independent pathways. 4) This in vivo
experiment confirmed previous in vitro studies indicating t h a t elevated
temperature increases the rate of proliferation of CD4+ T cells. Because of
the complex role played by CD4 + T cells in the immune system, it is difficult
to define the specific role of CD4+ T cells in the beneficial effect of elevated
temperature during T. cruzi infection. Further experiments will be required
to fully elucidate the role of CD4+ T cells in this phenomenon.
Several unexpected results occurred during the course of these
experiments. Enlarged spleens were found in mice injected with anti-CD4
monoclonal antibody and normal r a t IgG. This result suggests that mice
were mounting a significant immune response against the injected r a t

1

1

immunoglobulin. Repeated injection of the anti-CD4 monoclonal antibody
resulted in the death of some mice. Similar observations have not been
mentioned in previous studies. Severe wasting was also seen to occur in
mice maintained at 36°C. As a consequence, all of the mice died by day 70 of
infection even though the parasitemia levels fell to zero.

The possible

explanation for this phenomenon could be large quantities of IL-1 or TNF-a
produced by higher temperature and infection. (Duff, 1985)
Another unexpected result of this experiment was t h a t elevated
temperature was shown to stimulate the recovery of CD4+ T cells following
in vivo depletion with monoclonal antibody. Previous studies have shown
that elevated temperatures can increase the rate of proliferation of CD4+ T
cells ( Gern et al., 1991). The present study represents in vivo confirmation
of this phenomenon.
In conclusion, CD4+ T cells do participate in the enhanced immune
response to T. cruzi at elevated environment temperature, but the precise
functional role of CD4+ T cells is not yet known.
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